From tomorrow morning till Friday evening, Nagi Bioscience will attend the Hello Tomorrow Summit in Paris as one of the World’s TOP500 Deep-Tech Startups. We are glad to be one of the startups selected for a showcase of our technology during this event. Come to visit us at booth #14 on Friday morning and seeRead more about Nagi Bioscience at the Hello Tomorrow Summit in Paris[…]
We are delighted to announce that Nagi Bioscience has been chosen by Hello Tomorrow as one of the world’s TOP 500 deep-tech startups! Hello Tomorrow is a global not-for-profit organization created by deep tech entrepreneurs, with a mission to empower and connect the most promising deep-tech entreprises across the globe to accelerate the transfer of breakthrough technologies into real worldRead more about We made it to the TOP 500 in the Hello Tomorrow Global Challenge![…]
Our Business Plan was awarded as TOP 10, among 108 submitted projects! »Venture» is Switzerland’s premier startup competition, initiative of ETH Zurich, EPF Lausanne, Knecht Holding, the innovation promotion agency CTI and McKinsey & Company, Switzerland.
This prestigious prize is given annually by the “E. Naef Foundation for in vitro research” (FENRIV), established in 1998. The foundation assists researchers investigating scientific means for restricting the use of vivisection and generally promotes in vitro research. Our team has been awarded for its work on the development of a novel in vitro technologyRead more about Nagi Bioscience wins the Egon Naef Award 2017[…]
Our Business Idea (formerly known as Nematrix) was selected by the Jury Committee of >>venture>> 2015,out of a total of 107 submissions, as a TOP 10 winner of the business idea competition! The award ceremony took place at ETH Zurich in June 2015.